Company Active LTD

Company profile

Cis Oncology Limited

UK company 02431816, incorporated on 12 October 1989.

CIS Oncology | Experts in Automated Chemotherapy Prescribing

Our ChemoCare system is used by hundreds of NHS trusts across the UK and makes prescribing and patient management quicker, easier and more reliable, using the latest technology for access anywhere, any time.

Company number

02431816

Incorporated

12 Oct 1989

Companies House status

Active

Company identity

Founded / incorporated

12 October 1989

Company number 02431816

Verify at Companies House

Legal name

CIS ONCOLOGY LIMITED

Company type

LTD

Region

South East England

Registered address

Unknown

Insolvency history

No

Corporate ownership

Updated 07 Jul 2026 09:49

8 levels 1 ultimate controller

1

Company Active LTD

Cis Oncology Limited

CRN 02431816

2

Direct controller Active LTD

Cis Healthcare Limited

CRN 06001875

3

Intermediate controller Active LTD

System C Healthcare Limited

CRN 01754990

4

Intermediate controller Active LTD

H&Sc Technologies Limited

CRN 09017786

5

Intermediate controller Active LTD

Asclepius Bidco Limited

CRN 13177175

6

Intermediate controller Active LTD

Asclepius Cleanco Limited

CRN 13182955

7

Intermediate controller Active LTD

Asclepius Holdco Limited

CRN 13183040

8

Intermediate controller Active LTD

Asclepius Topco Limited

CRN 13182927

9

Ultimate controller

00140080

CRN 00140080

Company events

Reference milestones and recent Companies House filing stream events.

2 events

02 Sep

2026

Liquidation Voluntary Members Return Of Final Meeting

Insolvency

LIQ13 | Transaction MzU0MDMwODc3NWFkaXF6a2N4 | Paper/PDF filed

Published 03 Sep 2026 23:55

12 Oct

1989

Incorporated

Inception

Company registered at Companies House

Public funding

1 award

First funded

2011

Funded years

2011

Age at first award

22 years

Projects

2011 Collaborative R&D

Development of a fully integrated service for sequencing-based tumour profiling including data interpretation and commercialisation of assay panel kit products

1 Dec 2011 to 31 Dec 2014

Awarded

£147,319

Total cost £368,482

The aim of this project is to develop a tumour profiling assay based on targeted multiplexed enrichment and next generation sequencing (NGS) of clinically informative genes and variants. Oxford Gene Technology (OGT) will work closely with its partners in Birmingham and Southampton, and the CR-UK Technology hubs to build the assay into an innovative, integ...

Product types

Collaborative R&D